| 000 | 01052 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250516162859.0 | ||
| 264 | 0 | _c20140310 | |
| 008 | 201403s 0 0 eng d | ||
| 022 | _a1551-4005 | ||
| 024 | 7 |
_a10.4161/cc.25729 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOsawa, Tsuyoshi | |
| 245 | 0 | 0 |
_aTargeting cancer cells resistant to hypoxia and nutrient starvation to improve anti-angiogeneic therapy. _h[electronic resource] |
| 260 |
_bCell cycle (Georgetown, Tex.) _cAug 2013 |
||
| 300 |
_a2519-20 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJumonji Domain-Containing Histone Demethylases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 700 | 1 | _aShibuya, Masabumi | |
| 773 | 0 |
_tCell cycle (Georgetown, Tex.) _gvol. 12 _gno. 16 _gp. 2519-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4161/cc.25729 _zAvailable from publisher's website |
| 999 |
_c22967701 _d22967701 |
||